Authors


Virginia Bartok, RPh, MBA

Latest:

Blood Pressure and Cholesterol: Embracing New Guidelines

Two new guidelines have many clinicians, newscasters, and patients talking.


Kevin C. Maki, PhD, CLS, FNLA, Mary R. Dicklin, PhD

Latest:

Phytosterols for Lowering Cholesterol: Pharmacy Interventions to Improve Patient Outcomes

This Continuing Education activity is supported by an independent educational grant from Nature Made Nutritional Products.


Gloria Sachdev, PharmD

Latest:

Payment Models: Matching Patient Needs

As models for payment evolve, it's important to consider the best interests of the patient.


Steven Zabriski, MBA, BS Pharm, Senior Director, Payer Strategies, Acentrus Specialty

Latest:

Health-System Specialty Pharmacies Becoming an Industry Cornerstone

A new trend is emerging as health system–based specialty pharmacies become a staple in the industry.


Belinda L. Udeh, PhD, MPH

Latest:

Cost-Effectiveness of Stress Ulcer Prophylaxis: Role of Proton Pump Inhibitors

Proton pump inhibitors are cost-effective options for stress ulcer prophylaxis.


Breanna Sunderman, PharmD

Latest:

Adult Immunizations: Are Your Patients Up-to-Date?

In the health-system setting, pharmacists must often prioritize their attention to treating the most acute medical condition a patient presents with; however, it is important to also consider opportunities to prevent disease.


Kelly M. Johnson, MBA

Latest:

2010 Drug Utilization and Cost Trends for Antidiabetic Agents

The antihyperglycemic therapeutic class will continue to be a major contributor to prescription drug trends in 2011 and beyond.


Sean D. Sullivan, PhD

Latest:

Findings Related to Assessing Value for Private US Health Plans

A qualitative survey and quantitative database analysis of US payers indicated that determining whether they receive value for their expenditures involves substantial challenges.


Ginny Li, PharmD Candidate 2018

Latest:

Taking on AMCP Nexus: A First-Time Conference Experience

As one of Academy of Managed Care Pharmacy’s two annual conventions, AMCP Nexus aims to provide in-depth educational programming on the current advances and challenges in managed care.



Joanna L. Whyte, MS

Latest:

Synchronization of Treatment With Erythropoiesis-Stimulating Agents and Chemotherapy

In outpatient oncology clinics, erythropoiesis-stimulating agents and chemotherapy were found to be typically administered during the same visits, as opposed to requiring separate visits.




Tanvir T. Khan, MSc

Latest:

Outcomes of a Specialty Pharmacy Program for Oral Oncology Medications

Our research focuses on the clinical and economic outcomes of patients receiving care from a payer-designated specialty pharmacy program compared with regular retail pharmacies.


Karl Hess, PharmD, APh, CTH, FCPhA, FAPhA, AFTM RCPS (GLASG)

Latest:

Point-of-Care Testing Offers New Opportunities

Consider these steps for pharmacists to further evolve their role as the pandemic continues to put pressure on the health care system.



Michael S. Singer, MD, PhD

Latest:

An Intermittent Reinforcement Platform to Increase Adherence to Medications

An automated reinforcement platform was shown to increase statin adherence by 34.6%.



Founder

Latest:

Pharmacists Are Coming to the Rescue

As Pharmacy Times® goes to press this month, there is a lot of encouraging news on the coronavirus 2019 (COVID-19) front.


William D. Chey, MD

Latest:

US Primary Care Providers' Use of Over-the-Counter Medications for Gastroesophageal Reflux Disease and Chronic Constipation

The perception and utilization of OTC medications among primary care providers for gastroesophageal reflux disease and chronic constipation shows a need for improved patient education on these medications.


Amy J. Davidoff, PhD

Latest:

Utilization Impacts of New Oral Substitutes for Parenteral Cancer-Related Therapies

Examination of changes in utilization, dose adequacy, and duration associated with market entry of the oral chelator deferasirox as a potential substitute for parenteral deferoxamine.


Amanda Manoogian, PharmD, BCOP

Latest:

COVID-19 and the Impact on Oral Oncolytics: A Specialty Pharmacy Perspective

The increasing prevalence of oral oncolytics use, further accelerated by COVID-19, heightens the need for strong patient-pharmacist treatment coordination.


Rosemary Kerwin, PharmD

Latest:

Hepatitis C Case Study at Prosperity Specialty Pharmacy

Adherence for targeted therapies is even more essential now than it ever has been. This case study of services offered at a specialty pharmacy illustrates the impact of hepatitis C patients.


Leigh Anne Nelson, PharmD, BCPP

Latest:

Outpatient Adherence to Risperidone Long-Acting Injection Following Discharge From a State Psychiatric Hospital

Adherence to risperidone long-acting injection (RLAI) therapy in the outpatient setting was poor. Degree of discharge planning from inpatient hospitalization was not associated with RLAI adherence.



Paige Berger

Latest:

Integrated Pharmacy Savings Programs: A New Approach to Improve Satisfaction While Closing the Gaps in Coverage and Care

As we shift the healthcare paradigm, new ways to lower costs and improve adherence are worth another look.



Troyen A. Brennan, MD, JD

Latest:

Value-Based Insurance Design and Antidiabetic Medication Adherence

Among the commercially insured, pharmacy benefits define the availability, accessibility, and cost of prescription drugs.


Margaret A. Mendes, PharmD

Latest:

Evaluation of Therapeutic Interchange From Donepezil to Galantamine Extended-Release

Therapeutic interchange from donepezil to galantamine extended-release: a 3-month analysis.